|
DE2722113A1
|
|
Hypolipaemic combination preparations - contg. a nicotinic acid salt of a hypoglycaemic biguanide and the magnesium salt of clofibric acid
|
|
DE2639733A1
|
|
Antiarrhythmic 1-phenoxy-3-aminoethoxy-2-propanol derivs. - prepd. by reacting 1-phenoxy-2,3-epoxy-propane cpds. with 2-amino-ethanol cpds.
|
|
DE2639734A1
|
|
Amino-ethoxy-phenoxy-propanol(s) - useful as gastrointestinal smooth muscle inhibitors esp. as spasmolytics
|
|
DE2634620A1
|
|
Enzyme and hormone concentrates extn. from animal organs - using a supercritical gas, e.g. carbon di:oxide
|
|
DE2431126A1
|
|
Antiarrhythmic therapeutic agent - contg 1-(diethylamino-ethoxy)-3-(2-methoxy-phenoxy)-2-propanol as active ingredient
|
|
DE2410241A1
|
|
Dosage form for solid pharmaceuticals - consisting of small tablets prepd. by powder compression
|
|
DE2314256A1
|
|
Amino ethoxy phenoxy propanols - prepd. from corresp. 1,2-epoxy-3-phenoxy-propanes and diethlaminoethanol
|
|
DE2312912A1
|
|
Low-toxicity antiarrhythmic medicaments - contg. 1-phenoxy-3-(2-(diethylamino)ethoxy)-2-propanol
|
|
DE2021147A1
|
|
Medicinal capsule contg separate units
|
|
DE1967138A1
|
|
Hypolipaemic agents with reduced effect on glucose tolerance - contg. nicotinic acid and a biguanide nicotinate
|
|
DE1936274A1
|
|
Fibrinolysis promooting bigulanide nicotinates - for treating atherosclerosis
|
|
DE1044102B
|
|
Process for the preparation of esters of xanthene-9-carboxylic acid
|
